Oragenics (OGEN) Common Equity (2010 - 2026)
Oragenics' Common Equity came in at $3.67 million for Q2 2026, compared with -$2.13 million a year earlier and down 40.6% from the prior quarter.
Powered by 
Analysis
Oragenics (OGEN) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Oragenics' Common Equity was $8.28 million.
- Common Equity carries a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
- Going back by year, Common Equity was -$211,885 in FY2024, $3.17 million in FY2023 (-75.6%), $13.01 million in FY2022 (-50.9%) and $26.49 million in FY2021 (+57.2%).
- The five-year range for quarterly Common Equity is -$2.13 million (Q2 2025) to $28.55 million (Q3 2021).
- The fastest year-over-year change in Common Equity over five years came in Q3 2025 (growth of 219.5%), and the weakest in Q1 2025 (a decline of 94.8%).
- Business Quant data shows OGEN's Common Equity at $6.18 million (Q1 2026), $8.28 million (Q4 2025) and $9.83 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Oragenics | 1.89 Mn | -27.88 Mn | - | 3.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Mn |
| Mar 31, 2026 | 6.18 Mn |
| Dec 31, 2025 | 8.28 Mn |
| Sep 30, 2025 | 9.83 Mn |
| Jun 30, 2025 | -2.13 Mn |
| Mar 31, 2025 | 137,688.00 |
| Dec 31, 2024 | -211,885.00 |
| Sep 30, 2024 | 3.08 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 7.26 Mn |
| Mar 31, 2023 | 10.24 Mn |
| Dec 31, 2022 | 13.01 Mn |
| Sep 30, 2022 | 15.27 Mn |
| Jun 30, 2022 | 18.67 Mn |
| Mar 31, 2022 | 21.99 Mn |
| Dec 31, 2021 | 26.49 Mn |
| Sep 30, 2021 | 28.55 Mn |
API Access
Oragenics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();